T cell activity in successful treatment of chronic urticaria with omalizumab

Omalizumab, a humanized monoclonal anti-IgE antibody has the potential to alter allergen processing. Recently, it has been postulated the assessment of PHA-stimulated adenosine triphosphate (ATP) activity as maker of CD4+ T cells activity in peripheral blood cells. We present the case report of a 35...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Machín, Inmaculada, Iglesias-Souto, Javier, Franco, Andrés, Barrios, Yvelise, Gonzalez, Ruperto, Matheu, Víctor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159131/
https://www.ncbi.nlm.nih.gov/pubmed/21791043
http://dx.doi.org/10.1186/1476-7961-9-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159131/
https://www.ncbi.nlm.nih.gov/pubmed/21791043
http://dx.doi.org/10.1186/1476-7961-9-11

Ejemplares similares